Abstract:Background Early-stage oral squamous cell carcinoma (OSCC) patients have a one-in-four risk of regional metastasis (LN+), which is also the most significant prognostic factor for survival. As there are no validated biomarkers for predicting LN+ in early-stage OSCC, elective neck dissection often leads to over-treatment and under-treatment. We present a machine-learning-based model using the quantitative nuclear phenotype of cancer cells from the primary tumor to predict the risk of nodal disease. Methods and findings Tumor specimens were obtained from 35 patients diagnosed with primary OSCC and received surgery with curative intent. Of the 35 patients, 29 had well (G1) or moderately (G2) differentiated tumors, and six had poorly differentiated tumors. From each, two consecutive sections were stained for hematoxylin & eosin and Feulgen-thionin staining. The slides were scanned, and images were processed to curate nuclear morphometric features for each nucleus, measuring nuclear morphology, DNA amount, and chromatin texture/organization. The nuclei (n = 384,041) from 15 G1 and 14 G2 tumors were randomly split into 80% training and 20% test set to build the predictive model by using Random Forest (RF) analysis which give each tumor cell a score, NRS. The area under ROC curve (AUC) was 99.6% and 90.7% for the training and test sets, respectively. At the cutoff score of 0.5 as the median NRS of each region of interest (n = 481), the AUC was 95.1%. We then developed a patient-level model based on the percentage of cells with an NRS ≥ 0.5. The prediction performance showed AUC of 97.7% among the 80% (n = 23 patient) training set and with the cutoff of 61% positive cells achieved 100% sensitivity and 91.7% specificity. When applying the 61% cutoff to the 20% test set patients, the model achieved 100% accuracy. Conclusions Our findings may have a clinical impact with an easy, accurate, and objective biomarker from routine pathology tissue, providing an unprecedented opportunity to improve neck management decisions in early-stage OSCC patients.

Pathological factors associated with cervical lymph node metastasis in patients with early stage oral squamous cell carcinoma

Clinical Study on Occult Cervical Lymph Node Metastases in Patients with Oral Squamous Cell Carcinoma

Research progress on the neck management of oral squamous cell carcinoma with clinically node-positive neck

Biomarkers predictive of cervical metastasis in oral squamous cell carcinoma

Risk factors and impact of occult and skip metastasis in early-stage oral tongue squamous cell carcinoma

Frequency of lymph node metastases at different neck levels in patients with oral squamous cell carcinoma: a systematic review and meta-analysis

Assessment and Treatment Strategies for Occult Contralateral Lymph Node Metastasis in Hypopharyngeal Squamous Cell Carcinoma Patients with Ipsilateral Node-Positive Necks

Lymph nodes in oral squamous cell carcinoma: a comprehensive anatomical perspective

[Progress in evaluating the risk of lymph node metastasis in early colorectal cancer].

Occult metastasis is no burden factor in oral squamous cell carcinoma patients when adhering to a standardized approach in neck dissection

Prediction of Lymph Node Metastasis in Oral Squamous Cell Carcinoma Based on Protein Profile

Cervical Metastases of Oral Maxillary Squamous Cell Carcinoma: A Systematic Review and Meta‐analysis

Evaluation of Neck Control Strategies for Oral Squamous Cell Carcinoma of Stage I: Neck Dissection or Potential Immunotherapy

[Relevant Factors and Management for Patients with Squamous Carcinoma in Tongue Without Clinical Cervical Lymphatic Node Metastasis].

A Combined Prediction Model for Lymph Node Metastasis Based on a Molecular Panel and Clinicopathological Factors in Oral Squamous Cell Carcinoma

Clinical Analysis of Patients in cN0 OSCC and LevelⅡb Lymph Nodes Metastasis

Occult Cervical Lymph Node Metastases in 100 Consecutive Patients with Cn0 Tongue Cancer.

A Prediction Model of Nodal Metastasis in Cn0 Oral Squamous Cell Carcinoma Using Metabolic and Pathological Variables

Neck Management of Pathological N1 Oral Squamous Cell Carcinoma: a Retrospective Study.

Quantitative nuclear phenotype signatures predict nodal disease in oral squamous cell carcinoma

Risk Factors for Cervical Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma: A Retrospective Population–Based Study